GeneDx Holdings is facing a securities class action lawsuit following a 49% single-day crash in its stock price in May 2026. The decline is linked to a 94% write-off of assets associated with the acquisition of Fabric Genomics and poor Q1 2026 financial results. The lawsuit follows a significant drop in share value, which fell by $33.42 during the period in question.
GeneDx faces a securities class action following a 49% share price collapse triggered by a massive 94% write-off of assets from its Fabric Genomics acquisition.
Read the full storyGeneDx Holdings hit by securities litigation after a 94% write-off of Fabric Genomics assets triggered a massive May sell-off.
GeneDx Holdings faces a securities class action following a massive 94% write-off of its Fabric Genomics acquisition and a disastrous Q1 earnings report.